Article
Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma.
Cancer medicine - 1 Nov 2020
Jiang Junjie, Ding Yongfeng, Wu Mengjie, Chen Yanyan, Lyu Xiadong, Lu Jun, Wang Haiyong, Teng Lisong
Abstract excerpt
Several biomarkers such as tumor mutation burden (TMB), neoantigen load (NAL), programmed cell-death receptor 1 ligand (PD-L1) expression, and lactate dehydrogenase (LDH) have been developed for predicting response to immune checkpoint inhibitors (ICIs) in melanoma. However, some limitations including the undefined cut-off value, poor uniformity of test platform, and weak reliability of prediction have restricted...
Topics
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
- DNA Mutational Analysis
- Decision Support Techniques
- Female
- Humans
- Immune Checkpoint Inhibitors
- Immunogenetic Phenomena
